Show me the way to...
ASV therapy is contraindicated in patients with chronic, symptomatic heart failure (NYHA 2-4) with reduced left ventricular ejection fraction (LVEF ≤ 45%) and moderate to severe predominant central sleep apnea.
This webpage content is intended for Healthcare Professionals only, not for general public.
The content available through this website is for informational and educational purposes only and is not a substitute for the professional judgment of a health care professional in diagnosing and treating patients. ResMed does not give medical advice, nor does it provide medical or diagnostic services. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have seen or read on this Website. For more information, please refer to our Terms of Use.
© ResMed. All rights reserved.